Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 312 | 528 | 7,031 | 15,288 | 1,020 |
| Gross Profit | 312 | 528 | 7,031 | 15,288 | 1,020 |
| Operating Expenses | 57,511 | 7,931 | 13,172 | 13,048 | 13,056 |
| Operating Income | -57,199 | -7,403 | -6,141 | 2,240 | -12,036 |
| Other Income | 7,216 | 10 | 47 | 57 | 113 |
| Pre-tax Income | -49,983 | -7,393 | -6,094 | 2,297 | -11,923 |
| Net Income Continuous | -49,983 | -7,393 | -6,094 | 2,297 | -11,923 |
| Net Income | $-49,983 | $-7,393 | $-6,094 | $2,297 | $-11,923 |
| EPS Basic Total Ops | -5.07 | -0.95 | -0.81 | 4.98 | -6.24 |
| EPS Basic Continuous Ops | -5.07 | -0.95 | -0.81 | 4.98 | -6.22 |
| EPS Diluted Total Ops | -5.07 | -0.95 | -0.81 | 4.98 | -6.24 |
| EPS Diluted Continuous Ops | -5.07 | -0.95 | -0.81 | 4.98 | -6.22 |
| EBITDA(a) | $-57,077 | $-7,117 | $-5,846 | $2,556 | $-11,718 |